Free Trial

ExodusPoint Capital Management LP Buys New Stake in Bowhead Specialty Holdings Inc. (NYSE:BOW)

Bowhead Specialty logo with Finance background

ExodusPoint Capital Management LP acquired a new stake in Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund acquired 12,322 shares of the company's stock, valued at approximately $438,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Charles Schwab Investment Management Inc. bought a new position in Bowhead Specialty in the 3rd quarter valued at $1,829,000. BNP Paribas Financial Markets bought a new stake in Bowhead Specialty during the third quarter worth about $484,000. State Street Corp bought a new stake in Bowhead Specialty in the 3rd quarter worth approximately $1,426,000. Y Intercept Hong Kong Ltd bought a new position in Bowhead Specialty during the third quarter valued at approximately $317,000. Finally, Barclays PLC purchased a new position in shares of Bowhead Specialty during the third quarter worth approximately $479,000.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. JMP Securities boosted their target price on Bowhead Specialty from $38.00 to $40.00 and gave the stock a "market outperform" rating in a research note on Friday, April 11th. Keefe, Bruyette & Woods dropped their price objective on shares of Bowhead Specialty from $44.00 to $43.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. JPMorgan Chase & Co. increased their target price on Bowhead Specialty from $30.00 to $35.00 and gave the company a "neutral" rating in a report on Tuesday, April 8th. Finally, Piper Sandler initiated coverage on Bowhead Specialty in a report on Wednesday. They set an "overweight" rating and a $44.00 price target for the company. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $37.17.

Check Out Our Latest Report on Bowhead Specialty

Insiders Place Their Bets

In other news, Director Ava Schnidman bought 1,493 shares of the firm's stock in a transaction on Friday, February 28th. The shares were bought at an average cost of $33.41 per share, for a total transaction of $49,881.13. Following the completion of the transaction, the director now owns 1,893 shares in the company, valued at $63,245.13. This trade represents a 373.25 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Bowhead Specialty Stock Performance

NYSE BOW traded up $0.31 on Friday, hitting $40.14. 210,798 shares of the company's stock were exchanged, compared to its average volume of 212,890. The firm's 50-day moving average price is $36.29 and its two-hundred day moving average price is $34.02. Bowhead Specialty Holdings Inc. has a fifty-two week low of $22.14 and a fifty-two week high of $42.29.

Bowhead Specialty (NYSE:BOW - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $0.42 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.07. The business had revenue of $184.77 million during the quarter, compared to analyst estimates of $102.12 million. Research analysts expect that Bowhead Specialty Holdings Inc. will post 1.36 EPS for the current year.

Bowhead Specialty Profile

(Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Further Reading

Institutional Ownership by Quarter for Bowhead Specialty (NYSE:BOW)

Should You Invest $1,000 in Bowhead Specialty Right Now?

Before you consider Bowhead Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.

While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines